Pfizer Other Current Assets 2012-2026 | PFE

Pfizer other current assets for the quarter ending March 31, 2026 were $6.213B, a 12.47% decline year-over-year.

  • Pfizer other current assets for 2024 were $7.567B, a 14.87% decline from 2023.
  • Pfizer other current assets for 2023 were $8.889B, a 3.43% increase from 2022.
  • Pfizer other current assets for 2022 were $8.594B, a 124.97% increase from 2021.

Pfizer Other Current Assets 2012-2026 | PFE

  • Pfizer other current assets for 2024 were $7.567B, a 14.87% decline from 2023.
  • Pfizer other current assets for 2023 were $8.889B, a 3.43% increase from 2022.
  • Pfizer other current assets for 2022 were $8.594B, a 124.97% increase from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B